A label-free approach to airways disease: phenotypes, endotypes and treatable traits

A. Agusti (Barcelona, Spain)

Source: ERS Research Seminar 2017 – Precision medicine in airway diseases

Number: 1

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Agusti (Barcelona, Spain). A label-free approach to airways disease: phenotypes, endotypes and treatable traits. ERS Research Seminar 2017 – Precision medicine in airway diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Identification of asthma phenotypes based on extrapulmonary treatable traits Source: Virtual Congress 2020 – Physical activity and chronic lung disease: once a new kid, now growing up Year: 2020
Asthma endotypes: a new approach to classification of disease entities within asthma Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013
Treatment of severe stable COPD: the multidimensional approach of treatable traits Source: ERJ Open Res, 6 (3) 00322-2019; 10.1183/23120541.00322-2019 Year: 2020
Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease Source: Breathe, 17 (3) 210053; 10.1183/20734735.0053-2021 Year: 2021
COPD phenotypes and endotypes Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018
From phenotypes to endotypes of asthma Source: International Congress 2014 – PG03 Respiratory medicine: diagnosis to treatment from a mentor and junior perspective Year: 2014
Treatable traits: toward precision medicine of chronic airway diseases Source: Eur Respir J 2016; 47: 410-419 Year: 2016
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021 Year: 2022
The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019
A simple algorithm for the identification of clinical COPD phenotypes Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017 Year: 2017
Identifying adult asthma phenotypes using a clustering approach Source: Eur Respir J 2011; 38: 310-317 Year: 2011
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation Source: Eur Respir J 2011; 38: 749-751 Year: 2011
The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015
The omics approach to defining endotypes and personalising treatment pathways in asthma Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016
Genetic typing of bronchial asthma afflicted people according to polymorphous genes for the purpose of disease progress risk factors detection Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011